Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 87, Issue 1, 1999, Pages 50-54

  Lindeboom, Jerôme A H ^a,b   De Lange, Jan ^b   Van Den Akker, Hans P ^c  

^a University Of Amsterdam ^*

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c University of Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ARTICLE; ATYPICAL MYCOBACTERIOSIS; CASE REPORT; CHILD; CHRONIC DISEASE; FEMALE; HUMAN; INFANT; LYMPHATIC SYSTEM DISEASE; MICROBIOLOGY; NECK;

ANTI-BACTERIAL AGENTS; CHILD; CHRONIC DISEASE; CLARITHROMYCIN; FEMALE; HUMANS; INFANT; LYMPHATIC DISEASES; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NECK;

EID: 0032608725     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(99)70294-5     Document Type: Article

References (46)

1. Falworth SM, Simpson MT. Cervical lymphadenitis in children: the role of Mycobacterium avium-intracellulare. Br J Oral Maxillofac Surg 1996;34:511-4.
2. Sigalet D, Lees G, Fanning A. Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J Pediatr Surg 1992;27:1381-4.
3. Wolinsky E. Nontuberculous mycobacteria und associated diseases. American Review of Respiratory Diseases 1979;119:107-59.
4. Saitz EW. Cervical lymphadenitis caused by atypical mycobacteria. Pediatr Clin North Am 1981;28:823-39.
5. Cleary KR, Batsakis JG. Mycobacterial disease of the head and neck: current perspective [Pathologic Consultation]. Ann Otol Rhinol Laryngol 1995;104:830-3.
6. Olson NR. Nontuberculous mycobacterial infections of the face and neck: practical considerations. Laryngoscope 1981;91:1714-25.
7. Armstrong KL, James RW, Dawson DJ, Francis PW, Masters B. Mycobacterium haemophilum causing perihilar or cervical lympadenitis in healthy children. J Pediatr 1992;121:202-5.
8. Poole MD. Mycobacterial cervicofacial adenitis: changing concepts. Ear Nose Throat J 1993;72:728.
9. Kuypers FY, Zwierstra RP, De Langen ZJ. De chirurgische behandeling van lymfadenitis door niet-tuberculeuze myeobacterien bij kinderen. Ned Tijdschr Geneeskd 1995;139:2036-9.
10. Dautzenberg B, Saint Marc T, Meyohas C, Eliaszewitch M, Haniez F, Rogues AM, et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avian infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1993;153:368-72.
11. Robinson P, Farthing P, Scott GM, Bennet JH. Oral Mycobacterium avium complex infection in a patient with HIV related disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:177-9.
12. Green PA, Fordham von Reyn C, Smith RP Jr. Mycobacterium avium complex parotid lymphadenitis: succesful therapy with clarithromycin and ethambutol. Pediatr Infect Dis J 1993;12:615-7.
13. Kuhn SM, Rosen W, Wong A, Taj Jadavji. Treatment of Mycobacterium marinum facial abcess using clarithromycin. Pediatr Infect Dis J 1995;14:631-2.
14. Leverstein H, Snow GB. Ingezonden stuk: de chirurgische behandeling van lymfadenitis door niet-tuberculeuze mycobacterien bij kinderen. Ned Tijdschr Geneeskd 1995;139:2451-2.
15. Tessier MH, Amoric JC, Mechinaud F, Dubesser D, Litoux P, Stadier JF. Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children. Lancet 1994;334:1778.
16. Grange JM, Yates MD, Pozniak A. Bacteriogically confirmed non-tuberculous mycobacterial lymphadenitis in southeast England: a recent increase in the number of cases. Arch Dis Child 1995;72:516-7.
17. Olson NR, Arbor A. Atypical mycobacterial infections of the neck. Laryngoscope 1967;1376-89.
18. Pinder SE, Colville A. Mycobacterial cervical lymphadenitis in children: can histological assessment help differentiate infections caused by non-tuberculous mycobacteria from Mycobacterium tuberculosis'? Histopathology 1993;22:59-64.
19. Hoekstra MO, Gerritsen J. Typisch atypisch. Ned Tijdschr Geneeskd 1989;133:329-32.
20. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long term follow up. Clin Infect Dis 1995;20:954-63.
21. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, O'Brien RJ. Usefelness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis J 1992;11:450-6.
22. Haas WH, Kirschner P, Ziesing S, Bremer HJ, Bottger EC. Cervical lymphadenitis in a child caused by a previously unknown mycobacterium. J Infect Dis 1993;167:237-40.
23. Spark RP, Fried ML, Bean CK, Figueroa JM, Crowe P, Campbell DP. Non-tuberculous mycobacterial adenitis of childhood: the ten-year experience at a community hospital. American Journal of Disease in Children 1988;142:106-8.
24. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis 1992;15:1-12.
25. Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy: relation of etiologic agents to age. JAMA 1984;251:1286-8.
26. Bouza E, Diaz-Lopez MD, Moreno S, Bernaldo de Quiros JCL, Vicente T, Berenguer J. Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection. Arch Intern Med 1993;153:496-500.
27. Mitchison DA, Ellard GA, Grosset J. New antibacterial drugs for the treatment of mycobacterial disease in man. Br Med Bull 1988;44:757-74.
28. Dhooge I, Dhooge C, De Baets F, Van Cauwenberge P. Diagnostic and therapeutic management of atypical rnycobacteria infections in children. Eur Arch Otorhinolaryngol 1993;250:387-91.
29. Cox HJ, Brightwell AP, Riordan T. Non-tuberculous mycobacterial infections presenting as salivary gland masses in children: investigation and conservative treatment. J Laryngol Otol 1995;109:525-30.
30. Artenstein AW, Kim JH, Williams WJ, Chung RCY. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995;20:876-82.
31. Hawkins DB, Shindo ML, Kahlstrom EJ, MacLaughlin EF. Mycobacterial cervical adenitis in children: medical and surgical management, Ear Nose Throat J 1993;72:733-42.
32. Margileth AM, Chandra R, Altman P. Chronic lymphadenopathy due to mycobacterial infection. American Journal of Disease in Children 1984;138:917-22.
33. Schaad UB, Votteler TP, McCracken Jr. GH, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979;95:356-61.
34. Gravesteijn JH, Zwierstra RP. Klieren. Ned Tijdschr Geneeskd 1988;132:753-5.
35. Allesi DP, Dudley JP. Atypical mycobacteria-induced cervical adenitis: treatment by needle apiration. Arch Otolaryngol Head Neck Surg 1988;114:664-6.
36. Laag van der J, Pronk A, Pull ter Gunne AJ, Bax NMA. Niettuberculeuze mycobacteriele lymphadenitis. Ned Tijdschr Geneeskd 1990;134:904-8.
37. Kennedy TL. Curettage of nontuberculous mycobacterial cervical lymphadenitis. Arch Otolaryngol Head Neck Surg 1992;118:759-62.
38. MacKellar A. Diagnosis and management of atypical mycobacterial lymphadenitis in children. J Pediatr Surg 1976;11:85-9.
39. Williams RG, Douglas-Jones T. Mycobacterium marches back [Review Article]. J Laryngol Otol 1995;109:5-13
40. Taha AT, Davidson PT, Bailey WC. Surgical treatment of atypical mycobacterial lymphadenitis in children. Pediatr Infect Dis 1985;4:664-7.
41. Rappaport W, Dunnington G, Norton L, Ladin D, Peterson E, Ballard J. The surgical management of atypical mycobacterial soft-tissue infections. Surgery 1990;108:36-9.
42. Kanlikama M, Ozsahinoglu C, Akan E, Oczan K. Mycobacterial species causing cervicofacial infection in Turkey. Eur Arch Otorhinolaryngol 1993;250:237-9.
43. Mandell F, Wright PF. Treatment of atypical mycobacterial cervical adenitis with rifampin. Pediatrics 1975;55:39-43.
44. Clark JE, Magee JG, Cant AJ. Non-tuberculous mycobacterial lymphadenopathy. Arch Dis Child 1995;72:165-6.
45. Weits J, Sprenger HG, Ilic P, van Klingeren B, Steensma JT. Clarithromycin monotherapy of MAC-Mycobacterioses in AIDS patients [Letters to the Editor]. Neth J Med 1991;39:126-8.
46. Peters DH, Clissold SP. Clarithromycin: a review of its antimicrobial activity, pharmokinetic properties and therapeutic potential. Drugs 1992;44:117-64.